BackIntensity Therapeutics Overview
Intensity Therapeutics Inc

Intensity Therapeutics Target Price

Analysts' average 12-month price target for Intensity Therapeutics is $11.

Get informed when a big investor buys or sells

+ Follow

Share Price

$3.25

Average Target Price

$11.00238.5% upside

2 analysts in the last 4 months

High: $15 | Low: $7

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-19H.C. WainwrightSwayampakula Ramakanth$7115.4% upsideOpen
2026-08-11Industrial Alliance SecuritiesJames Molloy$15361.5% upsideOpen
2024-10-31H.C. WainwrightSwayampakula Ramakanth$1253746.2% upsideOpen

Intensity Therapeutics (INTS) FAQ

As of the most recent data, INTS shows a target price of $11. Scroll down for historical charts and peer comparison views.

If Intensity Therapeutics moved to the average analyst target of $11, shares would be roughly 238.5% higher than $3.25. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Intensity Therapeutics's earnings trajectory.

Besides this target price page, Stockcircle has Intensity Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $11) with ownership activity and broader fundamentals.